FEDERATED HERMES, INC. – Ultragenyx Pharmaceutical Inc. Transaction History
FEDERATED HERMES, INC. portfolio value:
$158.03M
portfolio value
FEDERATED HERMES, INC. quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.51% | 19.30K shares | -68.49M | $41.41 | 3.81M |
| Q2 2022 | share | Decrease | -4.78% | -190.63K shares | -63.05M | $59.66 | 3.79M |
| Q1 2022 | share | Increase | +0.02% | 858 shares | -45.66M | $72.62 | 3.98M |
| Q4 2021 | share | Decrease | -0.00% | -162 shares | -24.33M | $84.25 | 3.98M |
| Q3 2021 | share | Increase | +3.52% | 135.72K shares | -7.63M | $90.19 | 3.98M |
| Q2 2021 | share | Decrease | -1.56% | -61.09K shares | -78.24M | $95.35 | 3.85M |
| Q1 2021 | share | Decrease | -8.60% | -368.12K shares | -147.08M | $113.86 | 3.91M |
| Q4 2020 | share | Increase | +4.55% | 186.21K shares | 256.04M | $138.43 | 4.28M |
| Q3 2020 | share | Increase | +0.34% | 13.95K shares | 17.34M | $82.19 | 4.09M |
| Q2 2020 | share | Increase | +1.58% | 63.59K shares | 140.70M | $78.22 | 4.08M |
| Q1 2020 | share | Increase | +35.15% | 1.04M shares | 51.53M | $44.43 | 4.01M |
| Q4 2019 | share | Increase | +4.12% | 117.69K shares | 4.82M | $42.71 | 2.97M |
| Q3 2019 | share | Increase | +60.84% | 1.07M shares | 9.41M | $42.78 | 2.85M |
| Q2 2019 | share | Increase | +1.45% | 25.37K shares | -8.64M | $63.5 | 1.77M |
| Q1 2019 | share | Increase | +36.95% | 471.95K shares | 65.79M | $69.36 | 1.74M |
| Q4 2018 | share | Decrease | -13.94% | -206.95K shares | -57.77M | $43.48 | 1.27M |
| Q3 2018 | share | Increase | +4.71% | 66.72K shares | 4.34M | $76.34 | 1.48M |
| Q2 2018 | share | Increase | +18.18% | 218.06K shares | 47.80M | $76.87 | 1.41M |
| Q1 2018 | share | Increase | +8.97% | 98.69K shares | 10.10M | $50.99 | 1.19M |
| Q4 2017 | share | Increase | +181.10% | 709.2K shares | 30.19M | $46.38 | 1.10M |
| Q3 2017 | share | Decrease | -6.11% | -25.5K shares | -5.04M | $53.26 | 391.6K |
| Q2 2017 | share | 0.00% | 0 shares | -2.36M | $62.11 | 417.1K | |
| Q1 2017 | share | Decrease | -4.84% | -21.2K shares | -2.54M | $67.78 | 417.1K |
| Q4 2016 | share | Decrease | -0.97% | -4.3K shares | -581K | $70.31 | 438.3K |
| Q3 2016 | share | Decrease | -0.10% | -450 shares | 9.72M | $70.94 | 442.6K |
| Q2 2016 | share | 0.00% | 0 shares | -6.37M | $48.91 | 443.05K | |
| Q1 2016 | share | Increase | +10.82% | 43.25K shares | -16.80M | $63.31 | 443.05K |